Article
BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association
1 Nov 2018
Abstract excerpt
Expression of aberrantly spliced BRAF V600E isoforms (BRAF V600E ΔEx) mediates resistance in 13%-30% of melanoma patients progressing on RAF inhibitors. BRAF V600E ΔEx confers resistance, in part, through enhanced dimerization. Here, we uncoupled BRAF V600E ΔEx dimerization from maintenance of MEK-ERK1/2 signaling. Furthermore, we show BRAF V600E ΔEx association with its substrate, MEK, is enhanced and required...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
